IRIS
NARDONE, OLGA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.649
EU - Europa 1.587
NA - Nord America 1.377
SA - Sud America 333
AF - Africa 74
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.028
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.433
US - Stati Uniti d'America 1.299
RU - Federazione Russa 861
CN - Cina 664
IT - Italia 291
BR - Brasile 280
HK - Hong Kong 209
VN - Vietnam 163
DE - Germania 96
NL - Olanda 83
KR - Corea 63
GB - Regno Unito 48
CA - Canada 44
FR - Francia 39
FI - Finlandia 37
IN - India 34
AR - Argentina 25
IE - Irlanda 24
ZA - Sudafrica 23
PL - Polonia 22
MX - Messico 20
CI - Costa d'Avorio 18
BD - Bangladesh 15
RO - Romania 13
BG - Bulgaria 12
UA - Ucraina 10
AT - Austria 9
EC - Ecuador 9
ID - Indonesia 9
TR - Turchia 9
UZ - Uzbekistan 9
JP - Giappone 8
SE - Svezia 8
EG - Egitto 7
ES - Italia 7
KZ - Kazakistan 6
CO - Colombia 5
IQ - Iraq 5
KE - Kenya 5
MA - Marocco 5
VE - Venezuela 5
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
CH - Svizzera 2
CL - Cile 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PK - Pakistan 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KW - Kuwait 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NE - Niger 1
NO - Norvegia 1
NP - Nepal 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
Totale 6.026
Salva come PNG Salva come JPEG
Città #
Singapore 685
Hefei 342
Moscow 226
Hong Kong 209
Chandler 164
Beijing 135
Ashburn 114
Santa Clara 89
Naples 88
Ho Chi Minh City 66
Seoul 63
Los Angeles 62
Amsterdam 50
Hanoi 33
Redondo Beach 30
Buffalo 29
Munich 27
New York 27
The Dalles 27
Millbury 26
Napoli 26
São Paulo 25
Dallas 19
Boston 17
Frankfurt am Main 17
Seattle 17
Warsaw 17
Helsinki 16
Chicago 15
Montreal 15
Nanjing 15
Toronto 15
Des Moines 14
Boardman 13
Johannesburg 12
Sofia 12
Princeton 11
Kochi 10
Lawrence 10
Nuremberg 10
Redwood City 10
Rome 10
Atlanta 9
Brooklyn 9
Dublin 9
Mexico City 9
Tashkent 9
Düsseldorf 8
London 8
Wilmington 8
Da Nang 7
Haiphong 7
Jiaxing 7
Milan 7
Ottawa 7
Rio de Janeiro 7
Rochdale 7
Turku 7
Bucharest 6
Denver 6
Elk Grove Village 6
Kronberg 6
Phoenix 6
Tokyo 6
Vienna 6
Ankara 5
Bexley 5
Can Tho 5
Catania 5
Charlotte 5
Falkenstein 5
Hải Dương 5
Lappeenranta 5
Nairobi 5
New Delhi 5
Orem 5
San Francisco 5
Thái Nguyên 5
Belo Horizonte 4
Clifton 4
Dong Ket 4
Falls Church 4
Houston 4
Lauterbourg 4
Manchester 4
Nocera Inferiore 4
Portsmouth 4
Quito 4
Salt Lake City 4
San Jose 4
Stockholm 4
Tianjin 4
Tunis 4
Turin 4
Wroclaw 4
Agawam 3
Agropoli 3
Aracaju 3
Astana 3
Augusta 3
Totale 3.133
Salva come PNG Salva come JPEG
Nome #
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics 136
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience 131
Bowel damage in Crohn's disease: direct comparison of ultrasonography- and magnetic resonance-based Lemann index. 128
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 127
Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol 122
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 119
Psoriasis Features in Patients with Inflammatory Bowel Disease 118
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 117
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 116
Gut microbiota and Crohn's disease 116
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 115
Adherence in ulcerative colitis: an overview 114
Different profile of efficacy of thiopurines in ulcerative colitis and Crohn's disease 114
Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography 113
The burden of anaemia in patients with inflammatory bowel diseases 111
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 108
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 105
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers 104
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 102
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 101
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 101
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak 94
Gut microbiota and irritable bowel syndrome 93
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 91
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis 91
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study 90
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 89
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 87
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? 87
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers 85
Insights into disability and psycho-social care of patients with inflammatory bowel disease 82
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 82
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study 81
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 81
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 81
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 80
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting. 80
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era 77
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study 76
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease 75
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis 71
The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons 70
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy 69
Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease 69
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 65
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 63
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 63
New endoscopic tools in inflammatory bowel disease 61
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 57
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 57
Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis 54
Image-Enhanced Endoscopy Surveillance of Colon and Pouch Dysplasia in IBD 54
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 54
Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease? 52
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials 52
Small molecule oral targeted therapies in ulcerative colitis 50
Advancing perioperative optimization in Crohn's disease surgery with machine learning predictions 47
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 47
MMX mesalamine: A modern twist on a classic treatment 46
Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era 46
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 46
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis 45
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping review 44
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis 44
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?-Author's reply 44
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 43
Key challenges and care approaches in inflammatory pouch disorders: What can we do better? 43
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study 42
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 41
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab 40
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative 40
Image-Enhanced Endoscopy in the Surveillance of Colitis-Associated Neoplasia 39
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 37
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 37
Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy 36
Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease 36
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video) 36
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey 35
Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey 35
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission 33
Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease 31
Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research 31
AI and endoscopy/histology in UC: the rise of machine 31
Venous and arterial thromboembolism in out-patients with inflammatory bowel disease: a single center study. 27
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 27
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists 18
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey 12
Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring 11
null 1
Totale 6.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 7 3 5 12 1 3 7
2021/2022183 0 0 2 2 1 2 0 9 12 12 52 91
2022/2023333 30 44 6 29 43 38 3 30 42 46 15 7
2023/2024335 7 35 15 15 10 28 62 45 6 5 69 38
2024/20252.173 108 101 6 16 65 108 266 127 127 244 789 216
2025/20262.860 467 536 571 465 674 147 0 0 0 0 0 0
Totale 6.152